May 16, 2019, 4:30 pm — 5:30 pm
Venture Café, Havana Room
4240 Duncan Ave
St. Louis, MO 63110
The Institute of Clinical and Translational Sciences (ICTS), in collaboration with Venture Café, is hosting Precision Medicine Series on the third Thursday of every month! This month, join us to hear two scholars from Washington University, Professor of Radiation Oncology, David Curiel, MD, PhD and Associate Professor of Pediatrics and Neurology, Toni Pearson, MD, to talk about their respective works in gene therapy. Dr. Curiel will talk about his development of viral-based CRISPR/Cas9 vehicles to deliver gene therapy agents. Dr. Pearson also works with gene vector therapy, applying it to a rare brain disorder in children that causes severe physical disabilities, which in early research trials, is showing great promise.
For more information, please contact Tricia Salyer, Precision Medicine Navigator at ICTS, at firstname.lastname@example.org.